Evidence map›Paper›PMID 38334790›Full record

ArticlePsychopharmacology2024

Individual differences in GHB consumption in a new voluntary GHB self-administration model in outbred rats.

Casper J H Wolf, Marcia Spoelder, Harmen Beurmanjer, Ronald Bulthuis, Arnt F A Schellekens, Judith R Homberg

Open access · hybridAbstract read
In one paragraph

Article in Psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Casper J H WolfDonders Institute for Brain, Department of Psychiatry, Radboudumc, Cognition, and Behaviour, Reinier Postlaan 4, 6525 GC, Nijmegen, The Netherlands. casper.wolf@radboudumc.nl.ORCID http://orcid.org/0000-0002-8886-3745
Marcia SpoelderDepartment of Primary and Community Care, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands.
Harmen BeurmanjerNijmegen Institute for Scientist-Practitioners in Addiction (NISPA), 6525 HR, Nijmegen, The Netherlands.
Ronald BulthuisMetris B.V, 2132 NG, Hoofddorp, The Netherlands.
Arnt F A SchellekensDonders Institute for Brain, Department of Psychiatry, Radboudumc, Cognition, and Behaviour, Reinier Postlaan 4, 6525 GC, Nijmegen, The Netherlands.
Judith R HombergDonders Institute for Brain Cognition and Behaviour, Department of Cognitive Neuroscience, Radboudumc, 6525 EN, Nijmegen, The Netherlands.
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe use of the recreational drug gamma-hydroxybutyric acid (GHB) has increased over the past decade, concomitantly leading to a higher incidence of GHB use disorder. Evidence-based treatment interventions are hardly available and cognitive effects of long-term GHB use remain elusive. In order to study the development of GUD and the causal effects of chronic GHB consumption, a GHB self-administration model is required. EXPERIMENTAL APPROACH: Long Evans rats had access to GHB in their home cage according to a two-bottle choice procedure for 3 months. Intoxication and withdrawal symptoms were assessed using an automated sensor-based setup for longitudinal behavioral monitoring. Rats were trained in an operant environment according to a fixed ratio (FR) 1, 2, and 4 schedule of reinforcement. Addiction-like behaviors were assessed through progressive ratio-, non-reinforced-, and quinine-adulterated operant tests. In addition, the novel object recognition test and elevated plus maze test were performed before and after GHB self-administration to assess memory performance and anxiety-like behavior, respectively. KEY

resultsAll rats consumed pharmacologically relevant levels of GHB in their home cage, and their intake remained stable over a period of 3 months. No clear withdrawal symptoms were observed following abstinence. Responding under operant conditions was characterized by strong inter-individual differences, where only a subset of rats showed high motivation for GHB, habitual GHB-seeking, and/or continued responding for GHB despite an aversive taste. Male rats showed a reduction in long-term memory performance 3 months after home-cage GHB self-administration. Anxiety-like behavior was not affected by GHB self-administration. CONCLUSION AND IMPLICATIONS: The GHB self-administration model was able to reflect individual susceptibility for addiction-like behavior. The reduction in long-term memory performance upon GHB self-administration calls for further research into the cognitive effects of chronic GHB use in humans.

Indexed as

HydroxybutyratesSodium OxybateSubstance Withdrawal SyndromeAnimalsConditioning, OperantHumansIndividualityMaleRatsRats, Long-EvansSelf Administration4-hydroxybutyric acidHydroxybutyratesSodium OxybateDrug addictionGamma-hydroxybutyric acidGHBGHB use disorderSelf-administration modelSubstance use

Identifiers

PMID38334790
PMCPMC10884067
OpenAlexW4391683618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.